ATARA BIOTHERAPEUTICS INC (ATRA)
US0465131078 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 25.84M | 92.90M | 106.10M | 200.40M | 74.30M | |||
| Marketable Securities | 25.88M | 149.90M | 265.00M | 300.30M | 184.80M | |||
| Receivables | 34.11M | 40.20M | 1.00M | 1.30M | N/A | |||
| Inventories | 9.71M | 1.60M | N/A | N/A | N/A | |||
| Other Current Assets | 6.33M | 10.40M | 12.60M | 21.40M | 13.90M | |||
| Total Current Assets | 101.87M | 295.10M | 384.60M | 523.30M | 273.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 58.79M | 74.30M | 79.90M | 62.80M | 68.20M | |||
| Other Non-Current Assets | 4.84M | 7.00M | 3.60M | 2.00M | 1.80M | |||
| Total Non-Current Assets | 63.63M | 81.30M | 83.50M | 64.80M | 69.90M | |||
| TOTAL ASSETS | 165.50M | 376.40M | 468.10M | 588.10M | 342.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 915.00K | 800.00K | 200.00K | 300.00K | 300.00K | |||
| Accrued Expenses | 59.79M | 63.20M | 47.50M | 42.10M | 28.50M | |||
| Accounts Payable | 3.68M | 6.90M | 17.40M | 7.10M | 8.00M | |||
| Other Current Liabilities | 77.83M | 8.00M | 40.80M | 33.50M | N/A | |||
| Total Current Liabilities | 142.23M | 78.90M | 105.80M | 82.90M | 36.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 34.65M | 3.60M | 0.00 | 100.00K | 200.00K | |||
| Other Non-Current Liabilities | 87.86M | 167.20M | 82.70M | 42.70M | 15.20M | |||
| Total Non-Current Liabilities | 122.51M | 170.90M | 82.70M | 42.90M | 15.50M | |||
| TOTAL LIABILITIES | 264.74M | 249.80M | 188.50M | 125.80M | 52.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.97B | -1.69B | -1.46B | -1.12B | -818.00M | |||
| Additional Paid In Capital | 1.87B | 1.82B | 1.74B | 1.59B | 1.11B | |||
| Common Shares | 11.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -204.00K | -2.10M | -400.00K | 300.00K | 200.00K | |||
| Shares Outstanding | 106.45M | 95.90M | 91.70M | 83.40M | 56.80M | |||
| Tangible Book Value per Share | -0.93 | 1.32 | 3.05 | 5.54 | 5.12 | |||
| Total Shareholders' Equity | -99.23M | 126.60M | 279.60M | 462.30M | 290.80M | |||
| TOTAL LIABILITIES AND EQUITY | 165.50M | 376.40M | 468.10M | 588.10M | 342.90M | |||
| Statistics | ||||||||
| Debt/Equity | -0.35 | 0.03 | N/A | 0.00 | 0.00 | |||
| Current Ratio | 0.72 | 3.74 | 3.64 | 6.31 | 7.44 | |||
| Return On Assets (ROA) | -166.84% | -60.65% | -72.66% | -52.14% | -84.86% | |||
| Return On Equity (ROE) | N/A | -180.33% | -121.65% | -66.32% | -100.06% | |||
All data in USD